Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Naito

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
European Journal of Haematology|August 18, 2005
Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cellsMiki Kobayashi, Satoki Nakamura, Kiyoshi Shibata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 26, 2006
Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary musclesKeisuke Yamazaki, Hajime Terada, Hiroshi Satoh, et al.
Leukemia Research|July 28, 2005
Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cellsSatoki Nakamura, Miki Kobayashi, Kiyoshi Shibata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 11, 2019
[Postoperative Adjuvant Chemotherapy for Descending Colon Cancer Treated with Imatinib for Chronic Myeloid Leukemia]Kyota Tatsuta, Takashi Harada, Shinichiro Miyazaki, et al.
International Journal of Hematology|October 7, 2005
Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapiesKazuyuki Shigeno, Kensuke Naito, Naohi Sahara, et al.
Science Advances|May 17, 2017
The exceptional sediment load of fine-grained dispersal systems: Example of the Yellow River, ChinaHongbo Ma, Jeffrey A Nittrouer, Kensuke Naito, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2005
Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatmentKaori Shinjo, Akihiro Takeshita, Naohi Sahara, et al.
Internal Medicine (Tokyo, Japan)|November 1, 2005
High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal proteinMasanori Sakakima, Yoshihide Fujigaki, Takayuki Tsuji, et al.
International Journal of Hematology|June 8, 2006
Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapyKensuke Naito, Miki Kobayashi, Naohi Sahara, et al.
European Journal of Haematology|September 7, 2004
Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary componentsSatoki Nakamura, Reiko Nakamura, Kiyoshi Shibata, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
European Journal of Haematology|August 18, 2005
Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cellsMiki Kobayashi, Satoki Nakamura, Kiyoshi Shibata, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 26, 2006
Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary musclesKeisuke Yamazaki, Hajime Terada, Hiroshi Satoh, et al.
Leukemia Research|July 28, 2005
Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cellsSatoki Nakamura, Miki Kobayashi, Kiyoshi Shibata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 11, 2019
[Postoperative Adjuvant Chemotherapy for Descending Colon Cancer Treated with Imatinib for Chronic Myeloid Leukemia]Kyota Tatsuta, Takashi Harada, Shinichiro Miyazaki, et al.
International Journal of Hematology|October 7, 2005
Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapiesKazuyuki Shigeno, Kensuke Naito, Naohi Sahara, et al.
Science Advances|May 17, 2017
The exceptional sediment load of fine-grained dispersal systems: Example of the Yellow River, ChinaHongbo Ma, Jeffrey A Nittrouer, Kensuke Naito, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2005
Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatmentKaori Shinjo, Akihiro Takeshita, Naohi Sahara, et al.
Internal Medicine (Tokyo, Japan)|November 1, 2005
High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal proteinMasanori Sakakima, Yoshihide Fujigaki, Takayuki Tsuji, et al.
International Journal of Hematology|June 8, 2006
Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapyKensuke Naito, Miki Kobayashi, Naohi Sahara, et al.
European Journal of Haematology|September 7, 2004
Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary componentsSatoki Nakamura, Reiko Nakamura, Kiyoshi Shibata, et al.
Pageof 4